State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes

State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes

In recent years, several clinical trials focused on the potential role of immune-checkpoint inhibitors (ICIs) in the adjuvant treatment of muscle-invasive urothelial cancer (UC). Heretofore, only the anti-programmed death protein 1 (anti-PD1) nivolumab received European Medical Agency (EMA) approval...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elisa Tassinari, Linda Danielli, Andrea Marchetti, Matteo Rosellini, Costantino Ricci, Pietro Piazza, Angelo Mottaran, Riccardo Schiavina, Matteo Santoni, Veronica Mollica, Francesco Massari
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	Urothelial cancer bladder cancer adjuvant therapy immunotherapy muscle-invasive bladder cancer non-muscle invasive bladder cancer
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2440165
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of circulating tumor DNA (ctDNA) in urothelial cancers
by: Jeanny B. Aragon-Ching
Published: (2025-05-01)

Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer
by: Nannan Li, et al.
Published: (2025-08-01)

Incidence and Predictors of Secondary Upper Tract Urothelial Cancer in Patients with High-Risk Non-Muscle Invasive Urinary Bladder Cancer and its Impact on Imaging Surveillance: A Retrospective Analysis with 1501 Patients
by: Ebrahim Elsaeed Abouelenein, Mohamed Elawdy, Diaa-Eldin Taha, Yasser Osman, Bedeir Ali-El Dein, Ahmed Mosbah
Published: (2021-05-01)

Distant recurrence of non‐muscle invasive bladder cancer 8 years after initial treatment
by: Mahoro Watanabe, et al.
Published: (2024-11-01)

Results of chemoradiotherapyfor muscle-invasive bladder cancer
by: Yu. V. Gumenetskaya, et al.
Published: (2016-02-01)

Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohort
by: Aldéric Fraslin, et al.
Published: (2025-05-01)

Molecular genetic subtypes of non-muscle-invasive bladder cancer: their impact on disease prognosis
by: Sh. M. Sargsian, et al.
Published: (2025-07-01)

Significance of tumor-associated macrophages in bladder cancer development
by: V. N. Pavlov, et al.
Published: (2022-10-01)

A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
by: Chinna Babu Dracham, et al.
Published: (2022-07-01)

Clinical Utility of Bladder Cancer Biomarkers
by: Laura Maria Krabbe, Georgios Gakis, Yair Lotan
Published: (2020-10-01)

TREATMENT OF NON-MUSCLE-INVASIVE HIGH-RISK BLADDER CANCER
by: S. A. Ivanov, et al.
Published: (2017-07-01)

Comparison of thulium and holmium lasers with conventional transurethral bladder resection for non-muscle invasive bladder cancer
by: S. V. Popov, et al.
Published: (2024-07-01)

Diagnostic Performance and Interobserver Agreement of the Vesical Imaging–Reporting and Data System (VI-RADS) in Bladder Cancer Staging: A Systematic Review
by: Alexandru Nesiu, et al.
Published: (2025-03-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Urine microbiota in non-muscle-invasive bladder cancer and approaches to its detection
by: M. I. Kogan, et al.
Published: (2024-07-01)

Local immunity features in patients with non-invasive muscular bladder cancer of various degrees of malignance
by: A. B. Sagakyants, et al.
Published: (2022-12-01)

A novel bladder cancer surveillance schedule using bladder Cx for patients on annual surveillance
by: Arjun Guduguntla, et al.
Published: (2025-01-01)

Impact of regular cystoscopy on prognosis in non–muscle-invasive bladder cancer: A nationwide study
by: Jeong-Soo Kim, et al.
Published: (2025-07-01)

Efficacy of curative radiotherapy for the treatment of elderly patients with muscle-invasive bladder cancer: a systematic review
by: Masakuni Sakaguchi, et al.
Published: (2025-02-01)

Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy
by: Takeshi Sasaki, et al.
Published: (2025-03-01)

Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study
by: Junjie Ji, et al.
Published: (2025-07-01)

A histopathological and epidemiological study of urothelial carcinoma at a tertiary care centre in Peshawar, Pakistan
by: Saria Saeed, et al.
Published: (2024-05-01)

Histological and immunohistochemical approaches to molecular subtyping in muscle-invasive bladder cancer
by: Giulio Attanasio, et al.
Published: (2025-07-01)

3-year experience of hyperthermic intravesical chemotherapy use in patients with high risk non-muscular-invasive bladder cancer
by: R.S. Chystiakov, et al.
Published: (2023-06-01)

Flexible cystoscopy can improve anxiety and subjective feelings of bladder cancer patients during follow-up
by: Jie Gao, et al.
Published: (2020-11-01)

Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial
by: Federica Sordelli, et al.
Published: (2025-01-01)

Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
by: Chase Peng Yun Ng, et al.
Published: (2025-07-01)

Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?
by: Luca Scafuri, et al.
Published: (2021-10-01)

The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer
by: L. I. Belyakova, et al.
Published: (2022-03-01)

Unsupervised learning-based quantitative analysis of CT intratumoral subregions predicts risk stratification of bladder cancer patients
by: Ying Wang, et al.
Published: (2025-06-01)

Histomorphological pattern of lesions of cystoscopic bladder biopsies in a tertiary center in Nepal- A retrospective descriptive study
by: Amar Narayan Shrestha, et al.
Published: (2022-09-01)

High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
by: Roberta Lucianò, et al.
Published: (2025-05-01)

Correction: High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
by: Roberta Lucianò, et al.
Published: (2025-06-01)

Non-muscle invasive bladder cancer in a pregnant patient
by: Návan van Jaarsveld, et al.
Published: (2025-09-01)

A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden
by: Oscar Laurin, et al.
Published: (2024-09-01)

Advances in bladder preservation therapy for muscle-invasive bladder cancer
by: Ran Zhang, et al.
Published: (2025-05-01)

Efficacy and immunological effects of neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer
by: GAO Zhiqiang, CHEN Tao, LIU Lei, SUN Chunshan, JI Yilong, TANG Hao
Published: (2025-04-01)

Intravesical chemotherapy in BCG waiting period may prolong time to recurrence for high-risk NMIBC patients
by: Zhen Li, et al.
Published: (2025-02-01)

Prototol for the Prospective Sample Collection for Cancer of Bladder (ProCaB) Trial by the Cancer of the Bladder Leuven (CaBLe) Consortium
by: Murat Akand, et al.
Published: (2024-12-01)

RNA-seq profiling identified a three-lncRNA panel in serum as potential biomarker for muscle-invasive bladder cancer
by: Xiumei Jiang, et al.
Published: (2024-12-01)